Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to becoming a leader in developing and commercializing transformative therapies for autoimmune diseases. Our strategy combines an experienced leadership team with a disciplined approach to acquiring and advancing product candidates that deliver superior clinical benefits. We are advancing two potential autoimmune disease franchise molecules along with other pipeline and partnered programs for patients with autoimmune diseases.
For more information, visit www.zenasbio.com.